Kidney TransplantationTransplantsGraft RejectionGraft SurvivalImmunosuppressive AgentsHeart TransplantationTransplantation, HomologousTransplantationTissue DonorsLung TransplantationTissue and Organ ProcurementBone Marrow TransplantationCyclosporineTacrolimusLiving DonorsWaiting ListsPostoperative ComplicationsTreatment OutcomeImmunosuppressionHematopoietic Stem Cell TransplantationRetrospective StudiesTime FactorsFetal Tissue TransplantationCytomegalovirus InfectionsMycophenolic AcidHistocompatibility TestingCadaverTransplantation ImmunologyImmunocompromised HostKidney Failure, ChronicLiver FailureGraft vs Host DiseaseHeart-Lung TransplantationBrain Tissue TransplantationTransplantation, AutologousFollow-Up StudiesRisk FactorsBronchiolitis ObliteransTransplantation, HeterotopicHistocompatibilityTransplantation ToleranceOpportunistic InfectionsCytomegalovirusTransplantation ConditioningBK VirusRecurrenceSurvival RateSurvival AnalysisHLA AntigensBiopsyGanciclovirAntilymphocyte SerumIsoantibodiesPolyomavirus InfectionsKidneyLymphoproliferative DisordersEnd Stage Liver DiseaseTransplantation, IsogeneicProspective StudiesHematologic NeoplasmsIslets of Langerhans TransplantationCreatinineLiver DiseasesKidney DiseasesIncidenceMycosesPostoperative PeriodAcute DiseasePrimary Graft DysfunctionAntiviral AgentsWhole-Body IrradiationSirolimusFatal OutcomeStem Cell TransplantationPrognosisCalcineurinDirected Tissue DonationCohort StudiesPatient SelectionTransplantation ChimeraRenal DialysisCord Blood Stem Cell TransplantationDrug Therapy, CombinationInfectionLeukemiaBrain DeathRegistriesKaplan-Meier EstimateFacial TransplantationCyclosporinsProportional Hazards ModelsRisk AssessmentMultivariate AnalysisTissue TransplantationAspergillosisCorneal TransplantationReoperationGlomerular Filtration RateBlood Group IncompatibilitySkin Transplantation